The current proposal builds upon studies initiated in the previous project period that utilized biolumine- scent imaging (BLI) to assess the biology and treatment of HTLV-1 Tax lymphomas. A tumor transplant model and a transgenic mouse model were established for imaging to assess tumor cell proliferation and dissemination. Understanding the pathogenesis of HTLV-1 Tax lymphomas, through NFKB activation, has direct relevance to a wide range of hematopoietic neoplasms that also utilize NFKB activation.
The aims are:
Aim 1. Use of high throughput screen to identify kinases that are critical for Tax-mediatedlymphoma cell proliferation and/or survival. We will use a Tax transgenic tumor cell line for to screen the siRNA library to the human kinome to uncover new information about the transformation pathways exploited by HTLV-1.
Aim 2. Use of BLI to assess the role of critical mediators of Tax tumorigenesis in a tumor transplant model. Tumor cell lines expressing luciferase will be infected with a lentivirus expressing siRNAto a possible mediator of Tax activity. Mediators of Tax activityto be investigated include components of the NFKB pathway, upstream activators, and downstream NFKB targets. Critical kinase mediators, identified from Aim 1, will also be validated using a model with fresh tumor transplants. The cell lines are screened for high levels of luciferase activity, and injected subcutaneously into Rag1 mice. Mice are imaged every 2-4 wks over 12-16 wks with or without treatment with specific small molecule inhibitors, and tumors are then analyzed by immunohistochemistry for Tax and luciferase, as well as markers of cell proliferation (BUDR incorporation), angiogenesis (CD31 expression), and apoptosis (Tunel stain).
Aim 3. Use of BLI to assess the role of critical mediators of Tax tumorigenesis in a transgenic mouse model. This mouse model includes Tax and LTR-luciferase transgenes. These mice will be bred with mice with conditional or non-conditional homozygous deletions of genes expressing critical mediators of tumorigenesis, including tumor suppressor Arf, NFKB subunits p50 and p52, and kinases identified in Aim 1. Tumors will be evaluated by bioluminescent imaging, pathology, IHC for Tax and luciferase, FACSfor FcvRII/lll, CD4, or CD8, and markers of proliferation, angiogenesis, and apoptosis.
Aim 4. Use of BLI and CGH to assess the role of genetic instability in Tax tumorigenesis. The role of genetic instability in tumor initiation, maintenance, or progression will be evaluated in Tax transgenic animals that also express the CDC25A protein fused to click beetle red. These findings will be correlated to mouse comparative genomic hybridization (CGH) arrays.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Specialized Center (P50)
Project #
5P50CA094056-11
Application #
8233024
Study Section
Special Emphasis Panel (ZCA1)
Project Start
Project End
Budget Start
2011-01-01
Budget End
2011-12-31
Support Year
11
Fiscal Year
2011
Total Cost
$258,043
Indirect Cost
Name
Washington University
Department
Type
DUNS #
068552207
City
Saint Louis
State
MO
Country
United States
Zip Code
63130
Pisaneschi, Federica; Kelderhouse, Lindsay E; Hardy, Amanda et al. (2017) Automated, Resin-Based Method to Enhance the Specific Activity of Fluorine-18 Clicked PET Radiotracers. Bioconjug Chem 28:583-589
Zhu, Zhe; Gorman, Matthew J; McKenzie, Lisa D et al. (2017) Zika virus has oncolytic activity against glioblastoma stem cells. J Exp Med 214:2843-2857
Zhang, Daoxiang; Li, Lin; Jiang, Hongmei et al. (2017) Constitutive IRAK4 Activation Underlies Poor Prognosis and Chemoresistance in Pancreatic Ductal Adenocarcinoma. Clin Cancer Res 23:1748-1759
Lu, Zhi Hong; Kaliberov, Sergey; Sohn, Rebecca E et al. (2017) A new model of multi-visceral and bone metastatic prostate cancer with perivascular niche targeting by a novel endothelial specific adenoviral vector. Oncotarget 8:12272-12289
Miller, Jessica; Wang, Steven T; Orukari, Inema et al. (2017) Perfusion-based fluorescence imaging method delineates diverse organs and identifies multifocal tumors using generic near-infrared molecular probes. J Biophotonics :
Miller, Jessica P; Habimana-Griffin, LeMoyne; Edwards, Tracy S et al. (2017) Multimodal fluorescence molecular imaging for in vivo characterization of skin cancer using endogenous and exogenous fluorophores. J Biomed Opt 22:66007
Zacharias, Niki Marie; McCullough, Christopher; Shanmugavelandy, Sriram et al. (2017) Metabolic Differences in Glutamine Utilization Lead to Metabolic Vulnerabilities in Prostate Cancer. Sci Rep 7:16159
Gilson, Rebecca C; Black, Kvar C L; Lane, Daniel D et al. (2017) Hybrid TiO2 -Ruthenium Nano-photosensitizer Synergistically Produces Reactive Oxygen Species in both Hypoxic and Normoxic Conditions. Angew Chem Int Ed Engl 56:10717-10720
Tang, Rui; Habimana-Griffin, LeMoyne M; Lane, Daniel D et al. (2017) Nanophotosensitive drugs for light-based cancer therapy: what does the future hold? Nanomedicine (Lond) 12:1101-1105
Miller, Jessica P; Maji, Dolonchampa; Lam, Jesse et al. (2017) Noninvasive depth estimation using tissue optical properties and a dual-wavelength fluorescent molecular probe in vivo. Biomed Opt Express 8:3095-3109

Showing the most recent 10 out of 273 publications